1/15/2021  10:10:00 PM Chg. -0.14 Volume Bid1/15/2021 Ask1:41:48 AM Market Capitalization Dividend Y. P/E Ratio
241.99USD -0.06% 1.28 mill.
Turnover: 213.47 mill.
236.75Bid Size: 300 244.00Ask Size: 100 90.94 bill.USD 0.86% 43.45

Business description

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
 

Management board & Supervisory board

CEO
Kevin A. Lobo
Management board
Glenn Boehnlein, Andy Pierce, Bronwen R. Taylor, David G. Furgason, Irene B. Corbe, Jeanne M. Blondia, Jody K. Powell, Katherine A. Owen, M. Kathryn Fink, Preston Wells, Rob Fletcher, Sean C. Etheridge, Spencer Stiles, Timothy J. Scannel, Viju Menon, William E. Berry Jr., Yin C. Becker
Supervisory board
Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Roch Doliveux, Dr. Srikant M. Datar, Giovanni Caforio, Lisa M. Skeete Tatum, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy
 

Company data

Name: Stryker Corporation
Address: 2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA
Phone: +1-269-385-2600
Fax: +1-616-385-1062
E-mail: -
Internet: www.stryker.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 60.30%
IPO date: -

Investor relations

Name: Preston Wells
IR phone: -
IR Fax: -
IR e-mail: preston.wells@stryker.com

Main Shareholders

Freefloat
 
60.30%
T. Rowe Price Associates, Inc.
 
7.70%
The Vanguard Group, Inc.
 
7.60%
BlackRock, Inc.
 
7.00%
Ronda E. Stryker
 
6.20%
Greenleaf Trust
 
5.80%
John W. Brown
 
5.40%